3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
66
Recurrence
20
Neoplasms, Plasma Cell
8
Primary Myelofibrosis
3
Polycythemia Vera
3
Myeloproliferative Disorders
3
Renal Insufficiency
2
Plasmacytoma
2
Lymphoma, Non-Hodgkin
2
Immunoglobulin Light-chain Amyloidosis
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thrombocytosis
1
Thrombocythemia, Essential
1
Sarcoma, Kaposi
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Optic Nerve Glioma
1
Neurofibromatosis 1
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Intraocular Lymphoma
1
Hodgkin Disease
1
Glioma
1
Interventions
venetoclax
4
fludarabine phosphate
4
Peripheral Blood Stem Cell Transplantation
3
ibrutinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Mycophenolic Acid
2
Melphalan
2
Dexamethasone
2
pomalidomide
1
pembrolizumab
1
obinutuzumab
1
ixazomib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
auricularum
1
acalabrutinib
1
Sirolimus
1
RG7388
1
Nivolumab
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
Calcium Dobesilate
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Chromosome 17 deletion
×
pomalidomide
×
Clear all
NCT01745640
2026-02-05
IFM2010-02
University Hospital, Lille
Phase 2
Completed
63 enrolled